Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
607 Leser
Artikel bewerten:
(2)

Elsevier to Showcase Award-winning Clinical Decision Support Solutions at HIMSS20

Four-year KLAS Category Leader in Clinical Decision Support - Care Plans & Order Sets, 'Care Planning' among solutions to be featured

PHILADELPHIA, March 3, 2020 /PRNewswire/ -- Elsevier, a global leader in information analytics, specializing in science and health, will showcase its clinical decision support solutions at Booth #1859 at the Healthcare Information and Management Systems Society (HIMSS) 2020 annual meeting in Orlando, FL, USA, March 10-12, 2020.

Elsevier Logo

A key solution being demonstrated will be Elsevier's Care Planning solution, which was named a 2020 Category Leader for the Clinical Decision Support - Care Plans/Order Sets category by KLAS, the research firm which specializes in monitoring and reporting the performance of healthcare vendors.

Elsevier, in its most expansive HIMSS presence to date, will host a virtual thought leadership panel, solution demonstrations and networking events to focus on empowering knowledge. The company's virtual thought leadership panel of industry experts, starting at the top of every hour, is about 'The Path to Knowledge Driven Care'. The panel will provide insights on emerging technologies and solutions that make it possible to deliver better and more precise clinical guidance at the point of care.

"Through our rich legacy and experience in clinical care, we are able to integrate world-class clinical content at the point of care to better assist healthcare providers," said John Danaher, MD, President, Global Clinical Solutions, Elsevier. "Our award-winning solutions, like Care Planning and ClinicalPath, integrate our trusted evidence-based clinical information to support clinicians, so they can make informed decisions about the care of their patients."

In addition to the virtual panel, Elsevier demonstrations and events at HIMSS20 include:

  • New Solutions: Elsevier will demonstrate several new solutions, including 3D4Medical, Veridata and PatientPass.
  • Interoperability Showcase, Booth 8300-106: A demonstration of Elsevier's ClinicalPath solution for oncology care, titled 'Linking the Person, Research and Public Health'. The demonstration is jointly presented with nine other companies.
  • Innovation Live, Booth 8200-99: A four-kiosk booth, hosted by the Elsevier Technology Team, will demonstrate how Elsevier is leveraging next-generation technologies to advance CDS. Kiosk demonstrations will focus on advanced healthcare analytics, healthcare knowledge graphs, machine learning, and healthcare and health data management solutions.
  • International Symposiums: Sponsored with HIMSS, Elsevier will host three international symposiums for participants from the Middle East, Latin America and Brazil, throughout the event, to showcase their global commitment.

Elsevier representatives will be available to discuss how value-based care initiatives can be achieved through CDS and clinical pathways.

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Christopher Capot
Global Communications
Elsevier
+1-917-704-5174
c.capot@elsevier.com

Logo: https://mma.prnewswire.com/media/754760/Elsevier_Logo.jpg

© 2020 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.